Alnylam Pharmaceuticals to Appeal Patent Ruling Over Moderna’s COVID Vaccine Technology
Alnylam Pharmaceuticals has announced its intention to challenge a recent decision from the U.S. District Court in Delaware regarding two patents that were brought into question in relation to Moderna’s COVID-19 vaccine, Spikevax. Alnylam, headquartered in Cambridge, Massachusetts, had previously filed lawsuits against both Moderna and Pfizer Inc in Delaware last year, seeking compensation for …
Alnylam Pharmaceuticals to Appeal Patent Ruling Over Moderna’s COVID Vaccine Technology Read More »